Sleep as a viable target for early intervention in young children with ASD
Watch on-demand this insightful webinar that explored the critical early intervention period for young children with Autism Spectrum Disorder (ASD), often referred to as the “golden window.” This period may start earlier than traditionally thought, offering a unique opportunity to maximize developmental outcomes.
This educational and promotional event is organised and funded by Flynn Pharma Ltd and Neurim Pharmaceuticals (1991) Ltd (Neurim).
Your certificate will be available in your account once you have watched the on-demand video.

Login to get full access to this resource
Agenda
Learning Objectives
- Explore profound benefits of early intervention, emphasizing how timely and targeted approaches can significantly improve the lives of children with ASD
- Explore the clinical practice aspects of identifying and managing insomnia in children with ASD
- Provide valuable strategies and practical knowledge to enhance your practice and support the well-being of children with ASD and their families









